N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma

Long-Term N-Acetylcysteine Therapy in Systemic Sclerosis Interstitial Lung Disease: A Retrospective Study

(2017) E. Rosato et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Ameliorative Effects of Dimetylthiourea and N-Acetylcysteine on Nanoparticles Induced Cyto-Genotoxicity in Human Lung Cancer Cells-A549

(2011) Ritesh Kumar Srivastava et al.   PLoS One

Mechanisms of skin fibrosis in systemic sclerosis

(2010) Masatoshi JINNIN   JOURNAL OF DERMATOLOGY

High DNA Oxidative Damage in Systemic Sclerosis

(2010) J. AVOUAC et al.   JOURNAL OF RHEUMATOLOGY

Pygeum africanum: effect on oxidative stress in early diabetes-induced bladder

(2009) Dan Wang et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse

(2009) A. Servettaz et al.   JOURNAL OF IMMUNOLOGY

Induction of Autoimmunity in a Bleomycin-Induced Murine Model of Experimental Systemic Sclerosis: An Important Role for CD4+ T Cells

(2009) Hideaki Ishikawa et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma

(2008) Ayumi Yoshizaki et al.   AMERICAN JOURNAL OF PATHOLOGY